Table 1.
Baseline Demographics (ITT Population)
| Parameter | PCb (N=46) |
PC (N=52) |
|---|---|---|
| Gender (n [%]) | ||
| Female | 16 (34.8) | 21 (40.4) |
| Male | 30 (65.2) | 31 (59.6) |
| Age (years) | ||
| Median (range) | 62.8 (43.7, 82.4) | 64.3 (45.8, 85.2) |
| Race (n [%]) | ||
| African | 5 (10.9) | 5 (9.6) |
| Caucasian | 36 (78.3) | 37 (71.2) |
| Hispanic | 1 (2.2) | 0 (0.0) |
| Asian | 4 (8.7) | 10 (19.2) |
| Primary tumor diagnosis (n [%]) | ||
| Adenocarcinoma | 19 (41.3) | 18 (34.6) |
| Large cell | 3 (6.5) | 3 (5.8) |
| Mixed histology | 0 (0.0) | 2 (3.8) |
| Poorly differentiated NSCLC | 9 (19.6) | 13 (25.0) |
| Squamous cell | 13 (28.3) | 11 (21.2) |
| Other | 2 (4.3) | 5 (9.6) |
| Disease stage | ||
| Stage IIIA | 20 (43.5) | 27 (51.9) |
| Stage IIIB | 26 (56.5) | 25 (48.1) |
Abbreviations: ITT = intent to treat; N = total population size; n = number of patients; PC=pemetrexed/cisplatin; PCb=pemetrexed/carboplatin.